Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,468,962
+$532,513 QoQ
Shares Held
5,784
+51.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#2,617
of 4,664 holders
Holding Since
Mar 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Marex Group plc holds $405,541,812 across 9 Drug Manufacturers - General names. JNJ ranks #6 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
249,397 | $299,134,267 | |
| 2 | AMGN |
Amgen Inc
|
197,671 | $71,580,622 | |
| 3 | NVO |
Novo Nordisk A S
|
518,286 | $24,846,630 | |
| 4 | PFE |
Pfizer Inc
|
178,990 | $4,310,079 | |
| 5 | MRK |
Merck & Co., Inc.
|
13,315 | $1,710,977 | |
| 6 | JNJ |
Johnson & Johnson
This page
|
5,784 | $1,468,962 | |
| 7 | ABBV |
AbbVie Inc.
|
5,599 | $1,408,932 | |
| 8 | AZN |
Astrazeneca PLC
|
4,027 | $763,599 |
All Filings in JNJ
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,468,962 | 5,784 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $936,449 | 3,831 | Shares | Defined | 2026-05-13 | |
| 2025-06-30 | $634,065 | 4,151 | Shares | Defined | 2025-08-19 | |
| 2025-03-31 | $16,956,144 | 102,244 | Shares | Defined | 2026-04-02 | |
| 2024-12-31 | $18,729,301 | 129,507 | Shares | Defined | 2026-04-02 | |
| 2024-09-30 | $16,894,916 | 104,251 | Shares | Defined | 2026-04-07 | |
| 2024-06-30 | $818,788 | 5,602 | Shares | Defined | 2026-04-02 | |
| 2024-03-31 | $807,718 | 5,106 | Shares | Defined | 2026-04-02 | |
| 2023-12-31 | $1,545,613 | 9,861 | Shares | Defined | 2026-04-02 | |
| 2023-03-31 | $281,015 | 1,813 | Shares | Defined | 2026-04-02 | |
| No filing history on record for this holder in this stock. | ||||||